Change of Name

Recorded: 2012-12-06 Pages: 162

Assignor

BAYER SCHERING PHARMA AG

Executed: 2011-07-01

Assignee

BAYER PHARMA AKTIENGESELLSCHAFT

MULLERSTRASSE 178, BERLIN, 13353, GERMANY

Covered Properties (4)

Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition

Application: 10/580,711 →

Publication: US 2008/0026057

Solid, modified-release pharmaceutical dosage forms which can be administered orally

Application: 11/317,720 →

Publication: US 2007/0026065

Prevention and Treatment of Thromboembolic Disorders

Patent: 9,539,218 →

Application: 11/883,218 →

Publication: US 2009/0004265

Novel Polymorphous Form of 5-Chloro-N-({(5S)-2-Oxo-3[4-(3-Oxo-4-Morpholinyl)-Phenyl]-1,3-Oxazolidine-5-Yl}-Methyl)-2-Thiophene Carboxamide

Patent: 8,188,270 →

Application: 12/089,095 →

Publication: US 2010/0152189

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.